Literature DB >> 1350787

Liver giant mitochondria revisited.

N J Robertson1, C H Kendall.   

Abstract

AIMS: To examine the correlation between the severity of alcohol induced liver damage and the presence of intracytoplasmic red bodies (defined as periodic acid-Schiff diastase negative, globular, hyaline cytoplasmic inclusions larger in size than the hepatocyte nucleolus). To investigate the incidence of intracytoplasmic red bodies (ICRBs) in non-alcoholic liver disease.
METHODS: Liver biopsy specimens from 53 patients with alcoholic liver disease and 50 patients with a variety of nonalcohol related liver diseases were examined by light microscopy for the presence of ICRBs. For the 53 patients with alcoholic liver disease an assessment of recent alcohol consumption was made indirectly from measurements of red cell volume (MCV) and plasma gamma-glutamyl transferase (GGT). In addition, 10 liver biopsies with alcohol induced changes and ICRBs were examined by electron microscopy for the presence of mitochondrial aberrations including enlargement.
RESULTS: ICRBs were detected in 18 of the 53 liver biopsy specimens showing alcohol induced changes, and were more abundant in those showing more advanced changes. Those patients whose liver specimens contained ICRBs were found to have a significantly higher mean plasma GGT activity and mean MCV than those individuals whose liver biopsy specimens did not contain ICRBs. Two of the 50 liver biopsy specimens showing non-alcohol induced changes contained ICRBs. Giant mitochondria were not detected by electron microscopy, but this may reflect sampling.
CONCLUSIONS: The results of this study indicate that ICRBs are definitely associated with alcoholic liver disease and are more likely to be found in liver biopsy specimens showing more advanced alcohol induced damage, and when recent alcohol consumption has been high.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350787      PMCID: PMC495303          DOI: 10.1136/jcp.45.5.412

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Physiological and pathological changes in mitochondrial morphology.

Authors:  C ROUILLER
Journal:  Int Rev Cytol       Date:  1960

2.  Megamitochondria as a diagnostic marker for alcohol induced centrilobular and periportal fibrosis in the liver.

Authors:  J Junge; T Horn; P Christoffersen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Riboflavin and mouse hepatic cell structure and function. I. Ultrastructural alterations in simple deficiency.

Authors:  B Tandler; R A Erlandson; E L Wynder
Journal:  Am J Pathol       Date:  1968-01       Impact factor: 4.307

4.  Serum -glutamyl transpeptidase activity in alcoholism.

Authors:  S B Rosalki; D Rau
Journal:  Clin Chim Acta       Date:  1972-06       Impact factor: 3.786

5.  Induction of megamitochondria in the mouse liver by isonicotinic acid derivatives.

Authors:  T Wakabayashi; M Asano; S Kawamoto
Journal:  Exp Mol Pathol       Date:  1979-12       Impact factor: 3.362

6.  Biochemical and haematological markers of alcohol intake.

Authors:  T P Whitehead; C A Clarke; A G Whitfield
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

7.  Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease.

Authors:  M Bruguera; A Bertran; J A Bombi; J Rodes
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

8.  Chronic alcoholism with fatty metamorphosis of the liver. Mitochondrial alterations in hepatic cells.

Authors:  D J Svoboda; R T Manning
Journal:  Am J Pathol       Date:  1964-04       Impact factor: 4.307

9.  Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men.

Authors:  J Chick; N Kreitman; M Plant
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

10.  Significance of megamitochondria in alcoholic liver disease.

Authors:  A Chedid; C L Mendenhall; T Tosch; T Chen; L Rabin; P Garcia-Pont; S J Goldberg; T Kiernan; L B Seeff; M Sorrell
Journal:  Gastroenterology       Date:  1986-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.